Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
Warnings and Precautions
That is a dual GLP one GIP agonist
To make these side effects less, doctors might change how they give the shot or where they give it
US$ 21.66
US$ 21.20
US$ 25.20
